Means of "Kombilipen". Indications for use. annotation
The drug "Kombilipen", indications for usewhich will be given below, is a multivitamin complex. The composition contains thiamine hydrochloride (vitamin B1). This element helps to provide cells with glucose. With its deficiency, the cells deform and increase in size. This, in turn, causes their dysfunction. Pyridoxine hydrochloride (B6) takes part directly in the metabolic processes in the central nervous system. This component provides a normal impulse transmission, responsible for braking and excitation. B6 is also involved in the synthesis of epinephrine, norepinephrine, transport of the nerve envelope - sphingosine. Cyanocobalamin (B12) promotes hemopoiesis. The component ensures the formation of choline, the main substrate for the synthesis of acetylcholine, and also participates in the synthesis of nucleic and folic acids, myelin. Cyanocobalamin contributes to the regeneration properties of tissues.
Means of "Kombilipen". Indications for use
The drug is recommended for trigeminal neuralgianerve, polyneuropathy of different nature (diabetic and alcoholic including). With a pain syndrome against a background of pathologies of the spine, the medication "Kombilipen" is also prescribed. Indications for use in these cases are: lumboscialgia, cervical, radicular, cervico-brachial, lumbar syndrome, intercostal neuralgia. An agent is also prescribed for inflammation of the facial nerve.
The drug "Kombilipen" (pills) instructionrecommends drinking after eating. Dosage for adults - 1 pc. from 1 to 3 times / day. Duration of admission is determined by the doctor. At elevated dosages, the duration of therapy should not exceed 4 weeks. The medicine "Kombilipen" (injections) is prescribed intramuscularly. The recommended dosage is 2 ml each day. Injections are carried out for 5-7 days, after that - 2 ml not more than 3 times a week. The duration of therapy is determined by the doctor.
Side effects and contraindications
The agent is not assigned with an individualintolerance of its components, during prenatal period, nursing patients. It is not recommended therapy for patients with cardiovascular insufficiency. The drug "Kombilipen", the indications for use of which are listed above, can provoke allergic reactions. Usually, they appear against a background of individual hypersensitivity. Patients in such cases have angioedema, skin itching, urticaria. Negative consequences include hyperhidrosis, tachycardia, acne.
The combined use of the drug is not recommended."Kombilipen" with the drug "Levodopa" in connection with the probability of a decrease in the therapeutic activity of vitamin B6. Cyanocobalamin is incompatible with heavy metals and their compounds. It is not recommended simultaneous use of the drug "Kombilipen" with sodium phenobarbital, riboflavin, metabisulphite, dextrose. The incompatibility of B1 with compounds that have oxidation-reduction properties (acetate, iodide, mercury chloride and others) is noted.